Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 16/20 | 0.57 |
| ▸ | ESR1 | P03372 | 15/20 | 0.57 |
| ▸ | ESRRA | P11474 | 9/20 | 0.57 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA3 | P07451 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | TYR | P14679 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3054947 | 0.88 | ESR2 (0.74) | ESR2ESR1ESRRAMIFCA12 | |
| SCHEMBL3054952 | 0.88 | ESR2 (0.74) | ESR2ESR1ESRRAMIFCA12 | |
| SCHEMBL18386216 | 0.83 | ESR2 (0.60) | ESR2ESR1ESRRAEGFRDPP4 | |
| SCHEMBL3068441 | 0.78 | ESR2 (0.55) | ESR2ESR1ESRRA | |
| SCHEMBL3068439 | 0.78 | ESR2 (0.55) | ESR2ESR1ESRRA | |
| SCHEMBL14924032 | 0.78 | ESR2 (0.74) | ESR2ESR1ESRRA | |
| SCHEMBL14924116 | 0.78 | ESR1 (0.46) | ESR2ESR1ESRRADPP4 | |
| SCHEMBL3068500 | 0.77 | ESR1 (0.57) | ESR2ESR1ESRRAMIFCA12 | |
| SCHEMBL3068502 | 0.77 | ESR1 (0.57) | ESR2ESR1ESRRAMIFCA12 | |
| SCHEMBL2585597 | 0.73 | ESR2 (1.00) | ESR2ESR1ESRRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170014401-A1 | NUCLEAR RECEPTOR BINDING AGENTS | GTX, INC. | 2017-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170014401-A1 | NUCLEAR RECEPTOR BINDING AGENTS | ESRRB, ESRRG, ESRRA | ESR2 4/4885ESR1 28/4885ESRRA 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.